HU195800B
(en)
*
|
1983-10-13 |
1988-07-28 |
Sandoz Ltd |
Process for producing 4h-benzo/4,5/cylopenta/1,2-b/ thiofene derivatives and pharmaceutical compositions containing them
|
WO1985003707A1
(en)
*
|
1984-02-15 |
1985-08-29 |
Schering Corporation |
8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
|
DE3677842D1
(de)
*
|
1985-05-13 |
1991-04-11 |
Schering Corp |
Verfahren zur herstellung von piperidyliden-dihydrodibenzo(a,d)zykloheptenen und deren azoderivate, so hergestellte verbindungen und ihre anwendung zur vorbereitung von heilmitteln.
|
US4804666A
(en)
|
1985-08-14 |
1989-02-14 |
Schering Corporation |
Antiallergic 6,11-dihydro-11-(4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines
|
US5089496A
(en)
*
|
1986-10-31 |
1992-02-18 |
Schering Corporation |
Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
|
AU635400B2
(en)
*
|
1986-10-31 |
1993-03-18 |
Schering Corporation |
Intermediates for producing benzo(5,6)cycloheptapyridines
|
US5665726A
(en)
*
|
1986-10-31 |
1997-09-09 |
Schering Corporation |
Benzo[5,6]cycloheptapyridines, compositions and methods of use
|
US5438062A
(en)
*
|
1986-10-31 |
1995-08-01 |
Schering Corporation |
Benzo(5,6)cycloheptapyridines, compositions and methods of use
|
US4826853A
(en)
*
|
1986-10-31 |
1989-05-02 |
Schering Corporation |
6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
|
JPH0678315B2
(ja)
*
|
1988-04-28 |
1994-10-05 |
シェリング・コーポレーション |
新規なベンゾピリド‐ピペリジン、ピペリジリデンおよびピペラジン化合物、組成物、製造法および利用法
|
US4912222A
(en)
*
|
1988-06-17 |
1990-03-27 |
Fisons Corporation |
Antihistamines related to cyproheptadine
|
US4863931A
(en)
*
|
1988-09-15 |
1989-09-05 |
Schering Corporation |
Antihistaminic fluoro substituted benzocycloheptapyridines
|
US4990535A
(en)
*
|
1989-05-03 |
1991-02-05 |
Schering Corporation |
Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
|
CA2038417A1
(en)
*
|
1990-04-11 |
1991-10-12 |
Yasuo Ito |
Piperidine compounds, method for preparation thereof, and a pharmaceutical composition comprising the same
|
IL98572A
(en)
*
|
1990-06-22 |
1995-07-31 |
Schering Corp |
Bite-benzo or benzopyrido compounds Cyclohepta piperidine, piperidylidene and piperazine, preparations and methods of use.
|
AU8902591A
(en)
*
|
1990-10-10 |
1992-05-20 |
Schering Corporation |
Substituted imidazobenzazepines and imidazopyridoazepines
|
CA2093646A1
(en)
*
|
1990-10-10 |
1992-04-11 |
Jesse K. Wong |
Bis-benzo cyclohepta piperidylidene, piperidine and piperazine compounds, compositions and methods of use
|
AU665341B2
(en)
*
|
1990-12-18 |
1996-01-04 |
Wellcome Foundation Limited, The |
Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
|
KR920014799A
(ko)
*
|
1991-01-18 |
1992-08-25 |
나오가따 다이도 |
신규벤조[5,6]시클로헵타[1,2-b]피리딘 유도체 및 이를 함유하는 항알레르기제
|
EP0586560A1
(en)
*
|
1991-05-23 |
1994-03-16 |
Schering Corporation |
Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use
|
AU2392392A
(en)
*
|
1991-07-23 |
1993-02-23 |
Schering Corporation |
Novel benzopyrido piperylidene compounds, compositions, methods of manufacture and methods of use
|
ES2040177B1
(es)
*
|
1992-03-06 |
1994-05-16 |
S A Tamarang |
Procedimiento para la sintesis de la 8-cloro-6, 11-dihidro-11, (1-etoxicarbonil-4-piperidiliden) -5h-benzo (5,6) ciclohepta-(1,2-b) piridina.
|
WO1993020063A1
(en)
*
|
1992-03-27 |
1993-10-14 |
Schering Corporation |
Unbridged bis-aryl carbinol derivatives, compositions and methods of use
|
CZ236294A3
(en)
*
|
1992-03-27 |
1995-07-12 |
Schering Corp |
Bridge bis-aryl carbinol derivatives, preparations based thereon and their use
|
ES2042421B1
(es)
*
|
1992-05-22 |
1994-08-01 |
Uriach & Cia Sa J |
Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
|
US5314697A
(en)
*
|
1992-10-23 |
1994-05-24 |
Schering Corporation |
Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
|
US6746691B2
(en)
|
1993-09-20 |
2004-06-08 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
|
US6818229B1
(en)
|
1993-09-20 |
2004-11-16 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia
|
US6676967B1
(en)
|
1993-09-20 |
2004-01-13 |
Kos Pharmaceuticals, Inc. |
Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
|
US6080428A
(en)
*
|
1993-09-20 |
2000-06-27 |
Bova; David J. |
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
|
US6129930A
(en)
*
|
1993-09-20 |
2000-10-10 |
Bova; David J. |
Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
|
US6365588B1
(en)
|
1993-10-15 |
2002-04-02 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
US5721236A
(en)
*
|
1993-10-15 |
1998-02-24 |
Schering Corporation |
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
US5719148A
(en)
*
|
1993-10-15 |
1998-02-17 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
WO1995010514A1
(en)
*
|
1993-10-15 |
1995-04-20 |
Schering Corporation |
Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
US6075025A
(en)
|
1993-10-15 |
2000-06-13 |
Schering Corporation |
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
DE69429438T2
(de)
*
|
1993-10-15 |
2002-08-08 |
Schering Corp., Kenilworth |
Tricyclische carbamat-derivate zur inhibierung der g-protein funktion und für die behandlung von proliferativen erkrankungen
|
US5661152A
(en)
*
|
1993-10-15 |
1997-08-26 |
Schering Corporation |
Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
US5595997A
(en)
|
1994-12-30 |
1997-01-21 |
Sepracor Inc. |
Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
|
US7214683B1
(en)
|
1994-12-30 |
2007-05-08 |
Sepracor Inc. |
Compositions of descarboethoxyloratadine
|
US7211582B1
(en)
*
|
1994-12-30 |
2007-05-01 |
Sepracor Inc. |
Methods for treating urticaria using descarboethoxyloratadine
|
US5700806A
(en)
*
|
1995-03-24 |
1997-12-23 |
Schering Corporation |
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
US5684013A
(en)
*
|
1995-03-24 |
1997-11-04 |
Schering Corporation |
Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
|
US5891872A
(en)
*
|
1995-04-07 |
1999-04-06 |
Schering Corporation |
Tricyclic compounds
|
US5801175A
(en)
|
1995-04-07 |
1998-09-01 |
Schering Corporation |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
IL117798A
(en)
*
|
1995-04-07 |
2001-11-25 |
Schering Plough Corp |
Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
|
US5712280A
(en)
*
|
1995-04-07 |
1998-01-27 |
Schering Corporation |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
JP3779349B2
(ja)
*
|
1995-04-24 |
2006-05-24 |
興和株式会社 |
ピペリジン誘導体
|
JP3383499B2
(ja)
|
1995-11-30 |
2003-03-04 |
富士写真フイルム株式会社 |
ハロゲン化銀カラー写真感光材料
|
JPH09152696A
(ja)
|
1995-11-30 |
1997-06-10 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料
|
US5874442A
(en)
*
|
1995-12-22 |
1999-02-23 |
Schering-Plough Corporation |
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
|
EP1014972A4
(en)
*
|
1996-02-08 |
2004-12-08 |
Merck & Co Inc |
TREATMENT METHOD AND PHARMACEUTICAL COMPOSITION
|
JP3882224B2
(ja)
*
|
1996-05-31 |
2007-02-14 |
旭硝子株式会社 |
パロキセチンの製造方法
|
US5945429A
(en)
*
|
1996-09-13 |
1999-08-31 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
ID22002A
(id)
*
|
1996-09-13 |
1999-08-19 |
Schering Corp |
Derivatif benzosikloheptapiridin tersubstitusi yang berguna untuk penghalangan transferase protein farnesil
|
US5900421A
(en)
*
|
1997-02-11 |
1999-05-04 |
Sepracor Inc. |
Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
|
US5939426A
(en)
*
|
1997-02-28 |
1999-08-17 |
Sepracor Inc. |
Methods for treating urinary incontinence using descarboethoxyloratadine
|
SE509618C2
(sv)
|
1997-03-06 |
1999-02-15 |
Goeran Blomqvist |
Farmaceutisk komposition för behandling av s k restless legs
|
US5998620A
(en)
*
|
1997-03-25 |
1999-12-07 |
Schering Corporation |
Synthesis of intermediates useful in preparing tricyclic compounds
|
US6506767B1
(en)
|
1997-07-02 |
2003-01-14 |
Schering Corporation |
8-chloro-6,11-dihydro-11-(4-piperidylidine)-5H-benzo[5,6]cyclohepta[1-2-b] pyridine
|
US5869479A
(en)
*
|
1997-08-14 |
1999-02-09 |
Schering Corporation |
Treatment of upper airway allergic responses
|
EP1021436A1
(en)
*
|
1997-10-10 |
2000-07-26 |
Schering Corporation |
ETHYL 4-(8-CHLORO-5, 6-DIHYDRO-11H- BENZO 5,6]CYCLOHEPTA 1,2-b]PYRIDIN -11-YLIDENE)-1- PIPERIDENE CARBOXYLATE POLYMORPH
|
US6335347B1
(en)
*
|
1997-10-10 |
2002-01-01 |
Schering Corporation |
Ethyl 4-(8-chloro-5,6-dihydro-11 H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidene carboxylate polymorph
|
ES2226289T3
(es)
*
|
1998-06-30 |
2005-03-16 |
Pfizer Products Inc. |
Loratadina para uso como antiarritmico.
|
US6423721B1
(en)
|
1998-09-10 |
2002-07-23 |
Schering Corporation |
Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
|
US6372909B1
(en)
|
1998-11-20 |
2002-04-16 |
Schering Corporation |
Synthesis of intermediates useful in preparing tricyclic compounds
|
TW509680B
(en)
|
1998-11-20 |
2002-11-11 |
Schering Corp |
A compound and process for the preparation of tricyclic compound
|
AU2157100A
(en)
*
|
1998-12-18 |
2000-07-12 |
Schering Corporation |
Process for preparing tricyclic compounds having antihistaminic activity
|
US6271378B1
(en)
|
1998-12-18 |
2001-08-07 |
Schering Corporation |
Process for preparing tricyclic compounds having antihistaminic activity
|
US6686502B1
(en)
|
1999-03-26 |
2004-02-03 |
Ucb S.A. |
Compounds and methods for treatment of asthma, allergy and inflammatory disorders
|
PE20001566A1
(es)
*
|
1999-03-26 |
2001-02-05 |
Ucb Sa |
Piperazinas 1,4-sustituidas, piperidinas 1,4-sustituidas y 4-alquilidenilpiperidinas 1-sustituidas
|
US6894059B1
(en)
|
1999-03-26 |
2005-05-17 |
Ucb S.A. |
Compounds and methods for treatment of asthma, allergy and inflammatory disorders
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
US6100274A
(en)
*
|
1999-07-07 |
2000-08-08 |
Schering Corporation |
8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
|
US6475493B1
(en)
|
1999-09-02 |
2002-11-05 |
Norstrum Pharmaceuticals, Inc. |
Controlled release pellet formulation
|
US6267986B1
(en)
|
1999-09-24 |
2001-07-31 |
Ranbaxy Laboratories Limited |
Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
|
US6114346A
(en)
|
1999-10-22 |
2000-09-05 |
Schering Corporation |
Treating sleep disorders using desloratadine
|
WO2001045668A2
(en)
*
|
1999-12-20 |
2001-06-28 |
Schering Corporation |
Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
|
AU2276801A
(en)
|
1999-12-20 |
2001-07-03 |
Schering Corporation |
Extended release oral dosage composition
|
US7405223B2
(en)
|
2000-02-03 |
2008-07-29 |
Schering Corporation |
Treating allergic and inflammatory conditions
|
AU2001253602A1
(en)
|
2000-04-18 |
2001-10-30 |
Schering Corporation |
Synthesis of intermediates useful in preparing tricyclic compounds
|
WO2002036077A2
(en)
*
|
2000-11-06 |
2002-05-10 |
Andrx Pharmaceuticals, Inc. |
Once a day antihistamine and decongestant formulation
|
HU226998B1
(en)
|
2000-11-23 |
2010-04-28 |
Richter Gedeon Nyrt |
Desloratadine hemisulphate, process for the preparation thereof and pharmaceutical compositions containing the same
|
US6599913B1
(en)
*
|
2001-06-29 |
2003-07-29 |
Schering Corporation |
Treating allergic and inflammatory conditions
|
US6720002B2
(en)
|
2001-07-20 |
2004-04-13 |
R.P. Scherer Technologies, Inc. |
Antihistamine formulations for soft capsule dosage forms
|
US20030004179A1
(en)
*
|
2002-05-21 |
2003-01-02 |
Affrime Melton B |
Treating allergic and inflammatory conditions
|
US20040033257A1
(en)
*
|
2002-05-30 |
2004-02-19 |
Strides Inc. |
Pharmaceutical formulation in a drug delivery system and process for preparing the same
|
TW200400816A
(en)
*
|
2002-06-26 |
2004-01-16 |
Lilly Co Eli |
Tricyclic steroid hormone nuclear receptor modulators
|
US20040001885A1
(en)
*
|
2002-06-27 |
2004-01-01 |
Unchalee Kositprapa |
Rapidly disintegrating antihistamine formulation
|
US20040101563A1
(en)
*
|
2002-07-18 |
2004-05-27 |
Kundu Subhas C. |
Storage stable antihistaminic syrup formulations
|
US8092831B2
(en)
*
|
2002-11-08 |
2012-01-10 |
Andrx Pharmaceuticals, Llc |
Antihistamine and decongestant system
|
US6635654B1
(en)
|
2003-01-09 |
2003-10-21 |
Allergan, Inc. |
Ophthalmic compositions containing loratadine
|
EP1507774A1
(en)
*
|
2003-03-12 |
2005-02-23 |
Biogal Gyogyszergyar Rt. |
Processes for preparation of polymorphic forms of desloratadine
|
US20050026890A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
|
JP3881640B2
(ja)
*
|
2003-08-08 |
2007-02-14 |
塩野義製薬株式会社 |
ロラタジンを含むドライシロップ剤
|
EP1819329A2
(en)
*
|
2004-08-04 |
2007-08-22 |
Schering Corporation |
Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
|
US20060154948A1
(en)
*
|
2005-01-12 |
2006-07-13 |
Schering Corporation |
Treating allergic and inflammatory conditions
|
JP2008536922A
(ja)
*
|
2005-04-22 |
2008-09-11 |
テバ・ファーマシューティカルズ・ユーエスエー・インコーポレイテッド |
オランザピンの医薬用経口崩壊錠
|
ES2398960T3
(es)
*
|
2005-06-17 |
2013-03-22 |
Aft Pharmaceuticals Limited |
Composición farmacéutica novedosa y su uso en un método para el tratamiento de pacientes con cangestión mucosa de las vías respiratorias altas
|
US20080194823A1
(en)
*
|
2006-04-04 |
2008-08-14 |
Mayur Devjibhai Khunt |
Preparation of loratadine form i
|
CA2653953C
(en)
*
|
2006-06-01 |
2015-12-08 |
Schering-Plough Healthcare Products, Inc. |
Phenylephrine pharmaceutical formulations and compositions for colonic absorption
|
SG172660A1
(en)
*
|
2006-06-01 |
2011-07-28 |
Schering Corp |
Pharmaceutical compositions for sustained release of phenylephrine
|
NZ573174A
(en)
|
2006-06-01 |
2012-01-12 |
Msd Consumer Care Inc |
Sustained release pharmaceutical dosage form containing phenylephrine
|
WO2007143382A2
(en)
*
|
2006-06-07 |
2007-12-13 |
Morton Grove Pharmaceuticals, Inc. |
Oral liquid loratadine formulations and methods
|
EP2121031B1
(en)
|
2007-03-12 |
2013-10-16 |
Nektar Therapeutics |
Oligomer-antihistamine conjugates
|
US20090082385A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched desloratidine
|
WO2010021681A2
(en)
*
|
2008-08-18 |
2010-02-25 |
Combinatorx (Singapore) Pte. Ltd. |
Compositions and methods for treatment of viral diseases
|
JP2012530140A
(ja)
|
2009-06-16 |
2012-11-29 |
メルク・シャープ・アンド・ドーム・コーポレーション |
グルココルチコイド受容体アゴニストとしての新規[3,2−c]ヘテロアリールステロイド、組成物およびこの使用
|
US20110130711A1
(en)
*
|
2009-11-19 |
2011-06-02 |
Follica, Inc. |
Hair growth treatment
|
CA2690490C
(en)
|
2010-01-19 |
2012-06-26 |
Accucaps Industries Limited |
Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
|
JP5362151B2
(ja)
|
2011-09-29 |
2013-12-11 |
塩野義製薬株式会社 |
Pgd2拮抗剤及びヒスタミン拮抗剤からなるアレルギー性鼻炎治療用医薬
|
US10525057B2
(en)
|
2013-09-24 |
2020-01-07 |
Otsuka Pharmaceutical Co., Ltd. |
Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function
|
CN106478595B
(zh)
*
|
2016-09-18 |
2019-05-21 |
西安交通大学 |
氯雷他定晶型及其制备方法和用途
|
CN110845473B
(zh)
*
|
2019-10-08 |
2023-04-07 |
深圳市南山区人民医院 |
一种抗金黄色葡萄球菌毒力和生物被膜形成的抑制剂Lo-乙酸乙酯及其用途
|
CN110818685A
(zh)
*
|
2019-10-08 |
2020-02-21 |
深圳市南山区人民医院 |
一种抗金黄色葡萄球菌毒力和生物被膜形成的抑制剂Lo-异己基及其用途
|
CN110818684B
(zh)
*
|
2019-10-08 |
2023-04-07 |
深圳市南山区人民医院 |
一种抗金黄色葡萄球菌毒力和生物被膜形成的抑制剂Lo-SH及其用途
|
KR102242382B1
(ko)
|
2020-02-28 |
2021-04-20 |
삼익제약주식회사 |
용해성, 안정성 및 쓴맛이 개선된 로라타딘 함유 시럽 조성물
|
WO2022106923A1
(en)
|
2020-11-18 |
2022-05-27 |
BioPharma Synergies, S. L. |
Orodispersible powder composition comprising an antihistamine compound
|
CN112645928A
(zh)
*
|
2020-12-23 |
2021-04-13 |
常州大学 |
一种连续流制备氯雷他定ⅱ晶型的方法
|
CN113135893B
(zh)
*
|
2021-06-21 |
2022-02-11 |
北京鑫开元医药科技有限公司 |
苯并环庚烷并吡啶化合物、其制备方法及其用途
|
CN115778924A
(zh)
*
|
2022-12-22 |
2023-03-14 |
河北三禾实创生物科技有限公司 |
一种氯雷他定制剂及其制备方法
|